਍㰀栀攀愀搀㸀ഀഀ ਍伀氀攀瀀琀爀漀 ⠀吀爀愀稀漀搀漀渀攀 栀礀搀爀漀挀栀氀漀爀椀搀攀⤀ 䔀砀琀攀渀搀攀搀ⴀ爀攀氀攀愀猀攀 琀愀戀氀攀琀猀 ⠀䰀愀戀漀瀀栀愀爀洀 䔀甀爀漀瀀攀 䰀椀洀椀琀攀搀⤀ 䘀甀氀氀 瀀爀攀猀挀爀椀戀椀渀最 椀渀昀漀洀爀愀琀椀漀渀Ⰰ 䐀爀甀最 刀攀昀攀爀攀渀挀攀 䔀渀挀礀挀氀漀瀀攀搀椀愀ഀഀ ਍㰀䴀䔀吀䄀 一䄀䴀䔀㴀∀䐀攀猀挀爀椀瀀琀椀漀渀∀  䌀伀一吀䔀一吀㴀∀伀氀攀瀀琀爀漀 ⠀吀爀愀稀漀搀漀渀攀 栀礀搀爀漀挀栀氀漀爀椀搀攀⤀ 䔀砀琀攀渀搀攀搀ⴀ爀攀氀攀愀猀攀 琀愀戀氀攀琀猀 ⠀䰀愀戀漀瀀栀愀爀洀 䔀甀爀漀瀀攀 䰀椀洀椀琀攀搀⤀Ⰰ 䐀爀甀最 刀攀昀攀爀攀渀挀攀 䔀渀挀礀挀氀漀瀀攀搀椀愀 ⴀ 倀栀礀猀椀挀椀愀渀猀 倀䐀刀∀㸀ഀഀ ਍㰀猀挀爀椀瀀琀 氀愀渀最甀愀最攀㴀∀䨀愀瘀愀匀挀爀椀瀀琀∀㸀ഀഀ function AddToFaves_hp(){਍ऀ瘀愀爀 椀猀开㐀甀瀀 㴀 瀀愀爀猀攀䤀渀琀⠀渀愀瘀椀最愀琀漀爀⸀愀瀀瀀嘀攀爀猀椀漀渀⤀㬀ഀഀ var is_mac = navigator.userAgent.toLowerCase().indexOf("mac")!=-1;਍ऀ瘀愀爀 椀猀开椀攀   㴀 渀愀瘀椀最愀琀漀爀⸀甀猀攀爀䄀最攀渀琀⸀琀漀䰀漀眀攀爀䌀愀猀攀⠀⤀⸀椀渀搀攀砀伀昀⠀∀洀猀椀攀∀⤀℀㴀ⴀ㄀㬀ഀഀ var thePage = location.href;਍ऀ椀昀 ⠀琀栀攀倀愀最攀⸀氀愀猀琀䤀渀搀攀砀伀昀⠀✀⌀✀⤀℀㴀ⴀ㄀⤀ഀഀ thePage = thePage.substring(0,thePage.lastIndexOf('#'));਍ऀ椀昀 ⠀椀猀开椀攀 ☀☀ 椀猀开㐀甀瀀 ☀☀ ℀椀猀开洀愀挀⤀ ഀഀ window.external.AddFavorite(thePage,document.title);਍ऀ攀氀猀攀 椀昀 ⠀椀猀开椀攀 簀簀 搀漀挀甀洀攀渀琀⸀椀洀愀最攀猀⤀ഀഀ booker_hp = window.open(thePage,'booker_','menubar,width=325,height=100,left=140,top=60');਍ऀ⼀⼀戀漀漀欀攀爀开栀瀀⸀昀漀挀甀猀⠀⤀㬀ഀഀ }਍⼀⼀ⴀⴀ㸀ഀഀ ਍㰀猀琀礀氀攀 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀㸀ഀഀ A:link { text-decoration: none; color:#000066; }਍䄀㨀瘀椀猀椀琀攀搀 笀 琀攀砀琀ⴀ搀攀挀漀爀愀琀椀漀渀㨀 渀漀渀攀㬀  挀漀氀漀爀㨀⌀    㘀㘀㬀 紀ഀഀ A:active { text-decoration: none; color:#000066; }਍䄀㨀栀漀瘀攀爀 笀 琀攀砀琀ⴀ搀攀挀漀爀愀琀椀漀渀㨀 渀漀渀攀㬀 挀漀氀漀爀㨀⌀㤀㤀  ㌀㌀㬀 紀 ഀഀ a { text-decoration: none}਍㰀⼀猀琀礀氀攀㸀ഀഀ ਍㰀戀漀搀礀 琀漀瀀洀愀爀最椀渀㴀∀ ∀ 氀攀昀琀洀愀爀最椀渀㴀∀ ∀ 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀㸀ഀഀ
਍㰀琀愀戀氀攀  戀愀挀欀最爀漀甀渀搀㴀∀椀洀愀最攀猀⼀搀爀甀最猀戀最爀⸀最椀昀∀ 眀椀搀琀栀㴀∀㤀㜀㈀∀㸀㰀琀爀㸀㰀琀搀㸀ഀഀ | DRUGS INDEX | MANUFACTURERS INDEX | HEALTH | ANATOMY | GEOGRAPHY | USA STATISTICS | CHINA STATISTICS | JOBS | ਍㰀⼀琀愀戀氀攀㸀ഀഀ ਍㰀琀爀㸀㰀琀搀 挀漀氀猀瀀愀渀㴀∀㌀∀㸀㰀椀洀最 猀爀挀㴀∀椀洀愀最攀猀⼀氀椀渀攀㈀⸀最椀昀∀㸀㰀⼀琀搀㸀㰀⼀琀爀㸀ഀഀ ਍㰀琀搀 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 眀椀搀琀栀㴀∀㈀㐀㐀∀ 渀漀眀爀愀瀀㸀ഀഀ ਍㰀琀搀 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 眀椀搀琀栀㴀∀㜀㈀㠀∀ 渀漀眀爀愀瀀㸀ഀഀ ਍ഀഀ ਍㰀琀爀 栀攀椀最栀琀㴀∀㌀∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 渀漀眀爀愀瀀 甀渀椀琀猀㴀∀瀀椀砀攀氀猀∀㸀㰀琀搀 挀漀氀猀瀀愀渀㴀∀㌀∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 栀攀椀最栀琀㴀∀㌀∀ 眀椀搀琀栀㴀∀㤀㜀㈀∀ 渀漀眀爀愀瀀 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 渀漀眀爀愀瀀㸀ഀഀ ਍㰀琀爀 栀攀椀最栀琀㴀∀㌀∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 渀漀眀爀愀瀀 甀渀椀琀猀㴀∀瀀椀砀攀氀猀∀㸀㰀琀搀 挀漀氀猀瀀愀渀㴀∀㌀∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 栀攀椀最栀琀㴀∀㌀∀ 眀椀搀琀栀㴀∀㤀㜀㈀∀ 渀漀眀爀愀瀀 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 渀漀眀爀愀瀀㸀ഀഀ ਍㰀⼀琀愀戀氀攀㸀㰀琀愀戀氀攀 戀漀爀搀攀爀㴀∀ ∀ 戀最挀漀氀漀爀㴀∀⌀䘀䘀䌀䌀㤀㤀∀ 挀攀氀氀猀瀀愀挀椀渀最㴀∀ ∀ 挀攀氀氀瀀愀搀搀椀渀最㴀∀ ∀ 眀椀搀琀栀㴀∀㤀㜀㈀∀ 愀氀椀最渀㴀∀琀漀瀀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀ 栀猀瀀愀挀攀㴀∀ ∀ 瘀猀瀀愀挀攀㴀∀ ∀  甀渀椀琀猀㴀∀瀀椀砀攀氀猀∀㸀㰀琀爀㸀㰀琀搀 戀愀挀欀最爀漀甀渀搀㴀∀椀洀愀最攀猀⼀搀爀甀最猀戀最爀㈀⸀最椀昀∀ 眀椀搀琀栀㴀∀㈀  ∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀㸀ഀഀ ਍ഀഀ ਍㰀℀ⴀⴀ 匀椀琀攀匀攀愀爀挀栀 䜀漀漀最氀攀 ⴀⴀ㸀ഀഀ
਍㰀琀愀戀氀攀 戀漀爀搀攀爀㴀∀ ∀ 戀最挀漀氀漀爀㴀∀⌀䘀䘀䌀䌀㤀㤀∀㸀ഀഀ
਍㰀琀爀㸀ഀഀ ਍㰀琀搀㸀ഀഀ ਍㰀氀愀戀攀氀 昀漀爀㴀∀猀猀 ∀ 琀椀琀氀攀㴀∀匀攀愀爀挀栀 琀栀攀 圀攀戀∀㸀㰀昀漀渀琀 猀椀稀攀㴀∀ⴀ㄀∀ 挀漀氀漀爀㴀∀⌀      ∀㸀圀攀戀㰀⼀昀漀渀琀㸀㰀⼀氀愀戀攀氀㸀㰀⼀琀搀㸀ഀഀ ਍㰀⼀琀爀㸀ഀഀ
਍㰀昀漀渀琀 猀椀稀攀㴀∀ⴀ㈀∀㸀㰀戀爀㸀㰀⼀昀漀渀琀㸀ഀഀ Oleptro (Trazodone hydrochloride) Extended-release tablets (Labopharm Europe Limited)
਍ഀഀ
਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀搀漀洀愀椀渀猀∀ 瘀愀氀甀攀㴀∀琀栀攀漀搀漀爀愀⸀挀漀洀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀琀攀砀琀∀ 渀愀洀攀㴀∀焀∀ 猀椀稀攀㴀∀㈀㈀∀ 洀愀砀氀攀渀最琀栀㴀∀㈀㔀㔀∀ 瘀愀氀甀攀㴀∀∀ 椀搀㴀∀猀戀椀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ
਍㰀琀愀戀氀攀㸀ഀഀ
਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀爀愀搀椀漀∀ 渀愀洀攀㴀∀猀椀琀攀猀攀愀爀挀栀∀ 瘀愀氀甀攀㴀∀琀栀攀漀搀漀爀愀⸀挀漀洀∀ 挀栀攀挀欀攀搀 椀搀㴀∀猀猀㄀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ
਍㰀氀愀戀攀氀 昀漀爀㴀∀猀戀戀∀ 猀琀礀氀攀㴀∀搀椀猀瀀氀愀礀㨀 渀漀渀攀∀㸀匀甀戀洀椀琀 猀攀愀爀挀栀 昀漀爀洀㰀⼀氀愀戀攀氀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀挀氀椀攀渀琀∀ 瘀愀氀甀攀㴀∀瀀甀戀ⴀ㔀㤀㈀㌀㄀㄀㤀㠀㌀㌀㌀㌀ 㜀 ㄀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀挀栀愀渀渀攀氀∀ 瘀愀氀甀攀㴀∀㘀㌀㔀㠀㈀㠀㘀㔀㠀㔀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀漀攀∀ 瘀愀氀甀攀㴀∀䤀匀伀ⴀ㠀㠀㔀㤀ⴀ㄀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀昀氀愀瘀∀ 瘀愀氀甀攀㴀∀   㜀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀椀渀瀀甀琀 琀礀瀀攀㴀∀栀椀搀搀攀渀∀ 渀愀洀攀㴀∀挀漀昀∀ 瘀愀氀甀攀㴀∀䜀䄀䰀吀㨀⌀  㠀   㬀䜀䰀㨀㄀㬀䐀䤀嘀㨀⌀㌀㌀㘀㘀㤀㤀㬀嘀䰀䌀㨀㘀㘀㌀㌀㤀㤀㬀䄀䠀㨀挀攀渀琀攀爀㬀䈀䜀䌀㨀䘀䘀䘀䘀䘀䘀㬀䰀䈀䜀䌀㨀㌀㌀㘀㌀㤀㤀㬀䄀䰀䌀㨀    䘀䘀㬀䰀䌀㨀    䘀䘀㬀吀㨀      㬀䜀䘀一吀㨀    䘀䘀㬀䜀䤀䴀倀㨀    䘀䘀㬀䰀䠀㨀㔀 㬀䰀圀㨀㔀 㬀䰀㨀栀琀琀瀀㨀⼀⼀眀眀眀⸀琀栀攀漀搀漀爀愀⸀挀漀洀⼀椀洀愀最攀猀⼀椀琀愀开氀漀最漀开昀漀爀开最漀漀最氀攀开猀攀愀爀挀栀开㌀⸀樀瀀最㬀匀㨀栀琀琀瀀㨀⼀⼀眀眀眀⸀琀栀攀漀搀漀爀愀⸀挀漀洀⼀㬀䘀伀刀䤀䐀㨀㄀∀㸀㰀⼀椀渀瀀甀琀㸀ഀഀ ਍㰀⼀琀搀㸀㰀⼀琀爀㸀㰀⼀琀愀戀氀攀㸀ഀഀ ਍㰀℀ⴀⴀ 匀椀琀攀匀攀愀爀挀栀 䜀漀漀最氀攀 ⴀⴀ㸀ഀഀ ਍ഀഀ ਍ഀഀ
  • Highlights਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀䘀唀䰀䰀∀㸀䘀甀氀氀 倀爀攀猀挀爀椀戀椀渀最 䤀渀昀漀爀洀愀琀椀漀渀㰀⼀愀㸀ഀഀ
  • Chemical Structure਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀䤀一䐀䤀䌀䄀吀䤀伀一匀∀㸀䤀渀搀椀挀愀琀椀漀渀猀 愀渀搀 唀猀愀最攀㰀⼀愀㸀ഀഀ
  • Dosage/Administration਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀䌀伀一吀刀䄀䤀一䐀䤀䌀䄀吀䤀伀一匀∀㸀䌀漀渀琀爀愀椀渀搀椀挀愀琀椀漀渀猀㰀⼀愀㸀ഀഀ
  • Warnings/Precautions਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀䄀䐀嘀䔀刀匀䔀开刀䔀䄀䌀吀䤀伀一匀∀㸀䄀搀瘀攀爀猀攀 刀攀愀挀琀椀漀渀猀㰀⼀愀㸀ഀഀ
  • Drug Interactions਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀倀伀倀唀䰀䄀吀䤀伀一匀∀㸀匀瀀攀挀椀昀椀挀 倀漀瀀甀氀愀琀椀漀渀猀㰀⼀愀㸀ഀഀ
  • Drug Abuse and Dependence਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀伀嘀䔀刀䐀伀匀䄀䜀䔀∀㸀伀瘀攀爀搀漀猀愀最攀㰀⼀愀㸀ഀഀ
  • Description਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀䌀䰀䤀一䤀䌀䄀䰀开倀䠀䄀刀䴀∀㸀䌀氀椀渀椀挀愀氀 倀栀愀爀洀愀挀漀氀漀最礀㰀⼀愀㸀ഀഀ
  • Nonclinical Toxicology਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀匀吀唀䐀䤀䔀匀∀㸀䌀氀椀渀椀挀愀氀 匀琀甀搀椀攀猀㰀⼀愀㸀ഀഀ
  • How Supplied਍㰀氀椀㸀㰀愀 栀爀攀昀㴀∀⌀匀吀伀刀䄀䜀䔀∀㸀匀琀漀爀愀最攀⼀䠀愀渀搀氀椀渀最㰀⼀愀㸀ഀഀ
  • Patient Councseling਍ഀഀ ਍ഀഀ ਍㰀戀㸀ഀഀ

    - Drugs index
    ਍㰀愀 栀爀攀昀㴀∀洀愀渀甀昀愀挀琀甀爀攀爀猀⸀栀琀洀氀∀㸀ⴀ 䴀愀渀甀昀愀挀琀甀爀攀爀猀㰀⼀愀㸀㰀戀爀㸀ഀഀ - Feedback

    ਍㰀⼀昀漀渀琀㸀ഀഀ ਍㰀⼀琀搀㸀㰀琀搀 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 眀椀搀琀栀㴀∀㄀㐀∀㸀㰀⼀琀搀㸀㰀琀搀 戀最挀漀氀漀爀㴀∀眀栀椀琀攀∀ 眀椀搀琀栀㴀∀㔀㔀㠀∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀㸀ഀഀ

    ਍㰀昀漀渀琀 昀愀挀攀㴀∀愀爀椀愀氀∀ 猀椀稀攀㴀∀㌀∀㸀ഀഀ

    ਍㰀愀 渀愀洀攀㴀∀䠀䤀䜀䠀䰀䤀䜀䠀吀匀∀㸀ഀഀ ਍㰀倀㸀ഀഀ

    ਍䠀䤀䜀䠀䰀䤀䜀䠀吀匀 伀䘀 倀刀䔀匀䌀刀䤀䈀䤀一䜀 䤀一䘀伀刀䴀䄀吀䤀伀一ഀഀ

    ਍㰀⼀瀀㸀ഀഀ

    ਍㰀戀㸀吀栀攀猀攀 栀椀最栀氀椀最栀琀猀 搀漀 渀漀琀 椀渀挀氀甀搀攀 愀氀氀 琀栀攀 椀渀昀漀爀洀愀琀椀漀渀 渀攀攀搀攀搀 琀漀 甀猀攀 伀氀攀瀀琀爀漀 猀愀昀攀氀礀 愀渀搀 攀昀昀攀挀琀椀瘀攀氀礀⸀ 匀攀攀 昀甀氀氀 瀀爀攀猀挀爀椀戀椀渀最 椀渀昀漀爀洀愀琀椀漀渀 昀漀爀 伀氀攀瀀琀爀漀⸀㰀⼀戀㸀ഀഀ
    ਍㰀戀爀㸀ഀഀ ਍伀䰀䔀倀吀刀伀 ⠀琀爀愀稀漀搀漀渀攀 栀礀搀爀漀挀栀氀漀爀椀搀攀⤀ 攀砀琀攀渀搀攀搀ⴀ爀攀氀攀愀猀攀 琀愀戀氀攀琀猀ഀഀ
    ਍㰀戀爀㸀ഀഀ Initial U.S. Approval: 1981਍㰀⼀戀㸀ഀഀ

    ਍㰀搀椀瘀㸀ഀഀ

    ਍㰀琀愀戀氀攀 戀漀爀搀攀爀㴀∀㈀∀ 挀攀氀氀瀀愀搀搀椀渀最㴀∀㈀ ∀ 栀猀瀀愀挀攀㴀∀㈀ ∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 瘀猀瀀愀挀攀㴀∀㈀ ∀ 瘀愀氀椀最渀㴀∀琀漀瀀∀㸀ഀഀ ਍㰀琀搀㸀ഀഀ

    ਍㰀戀㸀圀䄀刀一䤀一䜀㨀 匀唀䤀䌀䤀䐀䄀䰀䤀吀夀 䄀一䐀 䄀一吀䤀䐀䔀倀刀䔀匀匀䄀一吀 䐀刀唀䜀匀ഀഀ
    See full prescribing information for complete boxed warning.਍㰀⼀挀攀渀琀攀爀㸀ഀഀ
    ਍䤀渀挀爀攀愀猀攀搀 爀椀猀欀 漀昀 猀甀椀挀椀搀愀氀 琀栀椀渀欀椀渀最 愀渀搀 戀攀栀愀瘀椀漀爀 椀渀 挀栀椀氀搀爀攀渀Ⰰ 愀搀漀氀攀猀挀攀渀琀猀 愀渀搀 礀漀甀渀最 愀搀甀氀琀猀 琀愀欀椀渀最 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀猀 昀漀爀 洀愀樀漀爀 搀攀瀀爀攀猀猀椀瘀攀 搀椀猀漀爀搀攀爀 ⠀䴀䐀䐀⤀ 愀渀搀 漀琀栀攀爀 瀀猀礀挀栀椀愀琀爀椀挀 搀椀猀漀爀搀攀爀猀⸀ 伀氀攀瀀琀爀漀 椀猀 渀漀琀 愀瀀瀀爀漀瘀攀搀 昀漀爀 甀猀攀 椀渀 瀀攀搀椀愀琀爀椀挀 瀀愀琀椀攀渀琀猀⸀㰀⼀戀㸀ഀഀ ਍㰀⼀琀爀㸀ഀഀ ਍㰀瀀㸀ഀഀ ਍㰀瀀㸀ഀഀ

    ਍㰀戀爀㸀㰀戀爀㸀ഀഀ ----------------------------- INDICATIONS AND USAGE ---------------------------਍㰀戀爀㸀㰀戀爀㸀ഀഀ Oleptro is indicated for the treatment of major depressive disorder.਍㰀甀氀㸀ഀഀ
  • Efficacy was established in one 8-week trial of Oleptro as well as in trials of trazodone immediate release formulation in patients with major depressive disorder.਍㰀⼀甀氀㸀ഀഀ

    ਍㰀戀爀㸀ഀഀ
    ਍㰀戀㸀ⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀ 䐀伀匀䄀䜀䔀 䄀一䐀 䄀䐀䴀䤀一䤀匀吀刀䄀吀䤀伀一 ⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀ㰀⼀戀㸀ഀഀ
      ਍㰀氀椀㸀匀琀愀爀琀椀渀最 搀漀猀攀㨀 ㄀㔀  洀最 漀渀挀攀 搀愀椀氀礀⸀ 䴀愀礀 戀攀 椀渀挀爀攀愀猀攀搀 戀礀 㜀㔀 洀最 瀀攀爀 搀愀礀 攀瘀攀爀礀 琀栀爀攀攀 搀愀礀猀⸀ 䴀愀砀椀洀甀洀 搀漀猀攀㨀 ㌀㜀㔀 洀最 瀀攀爀 搀愀礀⸀ഀഀ
    • Dosing at the same time every day in the late evening, preferably at bedtime, on an empty stomach.਍㰀氀椀㸀吀愀戀氀攀琀猀 猀栀漀甀氀搀 戀攀 猀眀愀氀氀漀眀攀搀 眀栀漀氀攀 漀爀 戀爀漀欀攀渀 椀渀 栀愀氀昀 愀氀漀渀最 琀栀攀 猀挀漀爀攀 氀椀渀攀Ⰰ 愀渀搀 猀栀漀甀氀搀 渀漀琀 戀攀 挀栀攀眀攀搀 漀爀 挀爀甀猀栀攀搀⸀ഀഀ
    • When discontinued, gradual dose reduction is recommended (2).਍㰀⼀甀氀㸀ഀഀ -------------------------- DOSAGE FORMS AND STRENGTHS -----------------------਍㰀甀氀㸀ഀഀ Bisectable tablets of 150 mg or 300 mg.਍㰀⼀甀氀㸀ഀഀ -------------------------------- CONTRAINDICATIONS ------------------------------਍㰀甀氀㸀ഀഀ None.਍㰀⼀甀氀㸀ഀഀ ---------------------------- WARNINGS AND PRECAUTIONS ------------------------਍㰀甀氀㸀ഀഀ
    • Clinical Worsening/Suicide Risk: Monitor for clinical worsening and suicidal thinking and behavior.਍㰀氀椀㸀匀攀爀漀琀漀渀椀渀 匀礀渀搀爀漀洀攀 漀爀 一攀甀爀漀氀攀瀀琀椀挀 䴀愀氀椀最渀愀渀琀 匀礀渀搀爀漀洀攀ⴀ氀椀欀攀 刀攀愀挀琀椀漀渀猀㨀 䠀愀瘀攀 戀攀攀渀 爀攀瀀漀爀琀攀搀 眀椀琀栀 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀猀⸀ 䐀椀猀挀漀渀琀椀渀甀攀 伀氀攀瀀琀爀漀 愀渀搀 椀渀椀琀椀愀琀攀 猀甀瀀瀀漀爀琀椀瘀攀 琀爀攀愀琀洀攀渀琀⸀ഀഀ
    • Activation of Mania/Hypomania: Screen for bipolar disorder and monitor for mania/hypomania.਍㰀氀椀㸀儀吀 倀爀漀氀漀渀最愀琀椀漀渀㨀 䤀渀挀爀攀愀猀攀猀 琀栀攀 儀吀 椀渀琀攀爀瘀愀氀⸀ 䄀瘀漀椀搀 甀猀攀 眀椀琀栀 搀爀甀最猀 琀栀愀琀 愀氀猀漀 椀渀挀爀攀愀猀攀 琀栀攀 儀吀 椀渀琀攀爀瘀愀氀 愀渀搀 椀渀 瀀愀琀椀攀渀琀猀 眀椀琀栀 爀椀猀欀 昀愀挀琀漀爀猀 昀漀爀 瀀爀漀氀漀渀最攀搀 儀吀 椀渀琀攀爀瘀愀氀⸀ഀഀ
    • Use in Patients with Heart Disease: Use with caution in patients with cardiac disease.਍㰀氀椀㸀伀爀琀栀漀猀琀愀琀椀挀 䠀礀瀀漀琀攀渀猀椀漀渀 愀渀搀 匀礀渀挀漀瀀攀㨀 䠀愀瘀攀 漀挀挀甀爀爀攀搀⸀ 圀愀爀渀 瀀愀琀椀攀渀琀猀 漀昀 爀椀猀欀 愀渀搀 猀礀洀瀀琀漀洀猀 漀昀 栀礀瀀漀琀攀渀猀椀漀渀⸀ഀഀ
    • Abnormal Bleeding: May increase the risk of bleeding. Use with NSAIDs, aspirin, or other drugs that affect coagulation may compound this risk.਍㰀氀椀㸀䤀渀琀攀爀愀挀琀椀漀渀 眀椀琀栀 䴀䄀伀䤀猀㨀 䐀漀 渀漀琀 甀猀攀 挀漀渀挀漀洀椀琀愀渀琀氀礀 漀爀 眀椀琀栀椀渀 ㄀㐀 搀愀礀猀 漀昀 洀漀渀漀愀洀椀渀攀 漀砀椀搀愀猀攀 椀渀栀椀戀椀琀漀爀猀⸀ഀഀ
    • Priapism: Has occurred. Warn male patients of this risk and how/when to seek medical attention.਍㰀氀椀㸀䠀礀瀀漀渀愀琀爀攀洀椀愀㨀 䌀愀渀 漀挀挀甀爀 椀渀 愀猀猀漀挀椀愀琀椀漀渀 眀椀琀栀 匀䤀䄀䐀䠀⸀ഀഀ
    • Potential for Cognitive and Motor Impairment: Has potential to impair judgment, thinking, and motor skills. Advise patients to use caution when operating machinery.਍㰀氀椀㸀䐀椀猀挀漀渀琀椀渀甀愀琀椀漀渀 匀礀洀瀀琀漀洀猀㨀 䴀愀礀 漀挀挀甀爀 眀椀琀栀 愀戀爀甀瀀琀 搀椀猀挀漀渀琀椀渀甀愀琀椀漀渀 愀渀搀 椀渀挀氀甀搀攀 愀渀砀椀攀琀礀 愀渀搀 猀氀攀攀瀀 搀椀猀琀甀爀戀愀渀挀攀⸀ 唀瀀漀渀 搀椀猀挀漀渀琀椀渀甀愀琀椀漀渀Ⰰ 琀愀瀀攀爀 伀氀攀瀀琀爀漀 愀渀搀 洀漀渀椀琀漀爀 昀漀爀 猀礀洀瀀琀漀洀猀⸀ഀഀ
    ਍㰀戀㸀ⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀ 䄀䐀嘀䔀刀匀䔀 刀䔀䄀䌀吀䤀伀一匀 ⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀⴀ㰀⼀戀㸀ഀഀ

    ਍䴀漀猀琀 挀漀洀洀漀渀 愀搀瘀攀爀猀攀 爀攀愀挀琀椀漀渀猀 ⠀椀渀挀椀搀攀渀挀攀 攀㔢─ 愀渀搀 琀眀椀挀攀 琀栀愀琀 漀昀 瀀氀愀挀攀戀漀⤀ 愀爀攀㨀 猀漀洀渀漀氀攀渀挀攀⼀猀攀搀愀琀椀漀渀Ⰰ 搀椀稀稀椀渀攀猀猀Ⰰ 挀漀渀猀琀椀瀀愀琀椀漀渀Ⰰ 瘀椀猀椀漀渀 戀氀甀爀爀攀搀⸀ഀഀ

    ਍㰀戀㸀吀漀 爀攀瀀漀爀琀 匀唀匀倀䔀䌀吀䔀䐀 䄀䐀嘀䔀刀匀䔀 刀䔀䄀䌀吀䤀伀一匀Ⰰ 挀漀渀琀愀挀琀 㰀愀 栀爀攀昀㴀∀栀琀琀瀀㨀⼀⼀眀眀眀⸀氀愀戀漀瀀栀愀爀洀⸀挀漀洀⼀∀ 琀愀爀最攀琀㴀∀开戀氀愀渀欀∀㸀㰀甀㸀䰀愀戀漀瀀栀愀爀洀㰀⼀甀㸀㰀⼀愀㸀 漀爀 䘀䐀䄀 愀琀 ㄀ⴀ㠀  ⴀ䘀䐀䄀ⴀ㄀ 㠀㠀 漀爀 㰀愀 栀爀攀昀㴀∀栀琀琀瀀㨀⼀⼀眀眀眀⸀昀搀愀⸀最漀瘀⼀洀攀搀眀愀琀挀栀∀ 琀愀爀最攀琀㴀开戀氀愀渀欀∀㸀眀眀眀⸀昀搀愀⸀最漀瘀⼀洀攀搀眀愀琀挀栀㰀⼀愀㸀⸀㰀⼀戀㸀ഀഀ
    ਍㰀戀爀㸀ഀഀ ---------------------------- DURG INTERACTIONS ------------------------਍㰀甀氀㸀ഀഀ
  • Monoamine Oxidase Inhibitors: Should not be used concomitantly with Oleptro.਍㰀氀椀㸀䌀一匀 䐀攀瀀爀攀猀猀愀渀琀猀㨀 吀爀愀稀漀搀漀渀攀 洀愀礀 攀渀栀愀渀挀攀 攀昀昀攀挀琀猀 漀昀 愀氀挀漀栀漀氀Ⰰ 戀愀爀戀椀琀甀爀愀琀攀猀Ⰰ 漀爀 漀琀栀攀爀 䌀一匀 搀攀瀀爀攀猀猀愀渀琀猀⸀ഀഀ
  • CYP3A4 Inhibitors: May necessitate lower dose of Oleptro.਍㰀氀椀㸀䌀夀倀㌀䄀㐀 䤀渀搀甀挀攀爀猀 ⠀攀⸀最⸀Ⰰ 挀愀爀戀愀洀愀稀攀瀀椀渀攀⤀㨀 䴀愀礀 渀攀挀攀猀猀椀琀愀琀攀 栀椀最栀攀爀 搀漀猀攀 漀昀 伀氀攀瀀琀爀漀⸀ഀഀ
  • Digoxin or Phenytoin: Monitor for increased serum levels.਍㰀氀椀㸀圀愀爀昀愀爀椀渀㨀 䴀漀渀椀琀漀爀 昀漀爀 椀渀挀爀攀愀猀攀搀 漀爀 搀攀挀爀攀愀猀攀搀 瀀爀漀琀栀爀漀洀戀椀渀 琀椀洀攀⸀ഀഀ
  • Serotonergic Medications: Serotonin syndrome has been reported.਍㰀氀椀㸀一匀䄀䤀䐀猀Ⰰ 䄀猀瀀椀爀椀渀 漀爀 漀琀栀攀爀 䄀渀琀椀挀漀愀最甀氀愀渀琀猀㨀 倀漀琀攀渀琀椀愀氀 昀漀爀 椀渀挀爀攀愀猀攀搀 爀椀猀欀 漀昀 戀氀攀攀搀椀渀最⸀ഀഀ ਍㰀戀爀㸀㰀戀爀㸀ഀഀ ----------------------- USE IN SPECIFIC POPULATIONS ------------------਍㰀甀氀㸀ഀഀ
  • Pregnancy: Based on animal data, may cause fetal harm (8.1).਍㰀氀椀㸀一甀爀猀椀渀最 䴀漀琀栀攀爀猀㨀 唀猀攀 眀椀琀栀 挀愀甀琀椀漀渀 ⠀㠀⸀㌀⤀⸀ഀഀ
  • Pediatric Patients: Oleptro is not approved in pediatric patients (8.4).਍㰀氀椀㸀刀攀渀愀氀 漀爀 䠀攀瀀愀琀椀挀 䤀洀瀀愀椀爀洀攀渀琀㨀 唀猀攀 眀椀琀栀 挀愀甀琀椀漀渀⸀ഀഀ ਍㰀戀爀㸀ഀഀ See PATIENT COUNSELING INFORMATION as well as MEDICATION GUIDE.਍㰀戀爀㸀㰀戀爀㸀ഀഀ Revised: 01/2010਍㰀戀爀㸀㰀戀爀㸀ഀഀ ---------------------------------------------------------------------------------------------------਍㰀戀爀㸀㰀戀爀㸀ഀഀ

    ਍㰀愀 渀愀洀攀㴀∀䘀唀䰀䰀∀㸀ഀഀ ਍㰀倀㸀ഀഀ

    ਍㰀䠀㐀㸀ഀഀ FULL PRESCRIBING INFORMATION਍㰀⼀䠀㐀㸀ഀഀ

    ਍㰀戀㸀䘀唀䰀䰀 倀刀䔀匀䌀刀䤀䈀䤀一䜀 䤀一䘀伀刀䴀䄀吀䤀伀一㨀 䌀伀一吀䔀一吀匀⨀㰀⼀戀㸀ഀഀ
    ਍㰀戀爀㸀ഀഀ 1 INDICATIONS AND USAGE਍㰀戀爀㸀ഀഀ
    ਍㈀ 䐀伀匀䄀䜀䔀 䄀一䐀 䄀䐀䴀䤀一䤀匀吀刀䄀吀䤀伀一ഀഀ
    ਍㰀戀爀㸀ഀഀ 3 DOSAGE FORMS AND STRENGTHS਍㰀戀爀㸀ഀഀ
    ਍㐀 䌀伀一吀刀䄀䤀一䐀䤀䌀䄀吀䤀伀一匀ഀഀ
    ਍㰀戀爀㸀ഀഀ 5 WARNINGS AND PRECAUTIONS਍㰀甀氀㸀ഀഀ 5.1 Clinical Worsening and Suicide Risk਍㰀戀爀㸀ഀഀ 5.2 Serotonin Syndrome or Neuroleptic Malignant Syndrome਍⠀一䴀匀⤀ⴀ氀椀欀攀 刀攀愀挀琀椀漀渀猀ഀഀ
    ਍㔀⸀㌀ 匀挀爀攀攀渀椀渀最 倀愀琀椀攀渀琀猀 昀漀爀 䈀椀瀀漀氀愀爀 䐀椀猀漀爀搀攀爀 愀渀搀 䴀漀渀椀琀漀爀椀渀最 昀漀爀ഀഀ Mania/Hypomania਍㰀戀爀㸀ഀഀ 5.4 QT Prolongation and Risk of Sudden Death਍㰀戀爀㸀ഀഀ 5.5 Use in Patients with Heart Disease਍㰀戀爀㸀ഀഀ 5.6 Orthostatic Hypotension and Syncope਍㰀戀爀㸀ഀഀ 5.7 Abnormal Bleeding਍㰀戀爀㸀ഀഀ 5.8 Interaction with MAOIs਍㰀戀爀㸀ഀഀ 5.9 Priapism਍㰀戀爀㸀ഀഀ 5.10 Hyponatremia਍㰀戀爀㸀ഀഀ 5.11 Potential for Cognitive and Motor Impairment਍㰀戀爀㸀ഀഀ 5.12 Discontinuation Symptoms਍㰀⼀甀氀㸀ഀഀ 6 ADVERSE REACTIONS਍㰀甀氀㸀㘀⸀㄀ 䌀氀椀渀椀挀愀氀 吀爀椀愀氀 䔀砀瀀攀爀椀攀渀挀攀ഀഀ
    ਍㘀⸀㈀ 倀漀猀琀洀愀爀欀攀琀椀渀最 䔀砀瀀攀爀椀攀渀挀攀㰀⼀甀氀㸀ഀഀ 7 DRUG INTERACTIONS਍㰀戀爀㸀ഀഀ
    ਍㠀 唀匀䔀 䤀一 匀倀䔀䌀䤀䘀䤀䌀 倀伀倀唀䰀䄀吀䤀伀一匀ഀഀ

      ਍㠀⸀㄀ 倀爀攀最渀愀渀挀礀ഀഀ
      ਍㠀⸀㌀ 一甀爀猀椀渀最 䴀漀琀栀攀爀猀ഀഀ
      ਍㠀⸀㐀 倀攀搀椀愀琀爀椀挀 唀猀攀ഀഀ
      ਍㠀⸀㔀 䜀攀爀椀愀琀爀椀挀 唀猀攀ഀഀ
      ਍㠀⸀㘀 刀攀渀愀氀 䤀洀瀀愀椀爀洀攀渀琀ഀഀ
      ਍㠀⸀㜀 䠀攀瀀愀琀椀挀 䤀洀瀀愀椀爀洀攀渀琀ഀഀ
    ਍㤀 䐀刀唀䜀 䄀䈀唀匀䔀 䄀一䐀 䐀䔀倀䔀一䐀䔀一䌀䔀ഀഀ
      ਍㤀⸀㄀ 䌀漀渀琀爀漀氀氀攀搀 匀甀戀猀琀愀渀挀攀ഀഀ
      ਍㤀⸀㈀ 䄀戀甀猀攀ഀഀ
    ਍㄀  伀嘀䔀刀䐀伀匀䄀䜀䔀ഀഀ
      ਍㄀ ⸀㄀ 䠀甀洀愀渀 䔀砀瀀攀爀椀攀渀挀攀ഀഀ
      ਍㄀ ⸀㈀ 䴀愀渀愀最攀洀攀渀琀 漀昀 伀瘀攀爀搀漀猀攀㄀㄀ഀഀ
    ਍䐀䔀匀䌀刀䤀倀吀䤀伀一ഀഀ
    ਍㰀戀爀㸀ഀഀ 12਍䌀䰀䤀一䤀䌀䄀䰀 倀䠀䄀刀䴀䄀䌀伀䰀伀䜀夀ഀഀ
      12.1਍䴀攀挀栀愀渀椀猀洀 漀昀 䄀挀琀椀漀渀ഀഀ
      ਍㄀㈀⸀㈀ഀഀ Pharmacodynamics਍㰀戀爀㸀ഀഀ 12.3਍倀栀愀爀洀愀挀漀欀椀渀攀琀椀挀猀ഀഀ
    ਍㄀㌀⸀㄀ഀഀ 13਍一伀一䌀䰀䤀一䤀䌀䄀䰀 吀伀堀䤀䌀伀䰀伀䜀夀ഀഀ
      ਍㄀㌀⸀㄀ 䌀愀爀挀椀渀漀最攀渀攀猀椀猀Ⰰ 䴀甀琀愀最攀渀攀猀椀猀Ⰰ 䤀洀瀀愀椀爀洀攀渀琀 漀昀 䘀攀爀琀椀氀椀琀礀ഀഀ
    ਍㰀戀爀㸀㰀戀爀㸀ഀഀ 14਍䌀䰀䤀一䤀䌀䄀䰀 匀吀唀䐀䤀䔀匀ഀഀ
    ਍㰀戀爀㸀ഀഀ
    ਍㄀㘀ഀഀ HOW SUPPLIED/STORAGE AND HANDLING਍㰀戀爀㸀ഀഀ
    ਍㄀㜀ഀഀ PATIENT COUNSELING INFORMATION਍㰀戀爀㸀ഀഀ
    ਍⨀ഀഀ Sections or subsections omitted from the full prescribing information are਍渀漀琀 氀椀猀琀攀搀⸀ഀഀ

    ਍㰀栀爀㸀ഀഀ ਍㰀戀㸀䘀唀䰀䰀 倀刀䔀匀䌀刀䤀䈀䤀一䜀 䤀一䘀伀刀䴀䄀吀䤀伀一㰀⼀戀㸀ഀഀ

    ਍㰀琀愀戀氀攀 挀攀氀氀瀀愀搀搀椀渀最㴀∀㈀ ∀ 戀漀爀搀攀爀㴀∀㈀∀㸀㰀琀爀㸀㰀琀搀㸀ഀഀ ਍圀䄀刀一䤀一䜀㨀 匀唀䤀䌀䤀䐀䄀䰀䤀吀夀 䄀一䐀 䄀一吀䤀䐀䔀倀刀䔀匀匀䄀一吀 䐀刀唀䜀匀ഀഀ

    ਍䄀渀琀椀搀攀瀀爀攀猀猀愀渀琀猀 椀渀挀爀攀愀猀攀搀 琀栀攀 爀椀猀欀 挀漀洀瀀愀爀攀搀 琀漀 瀀氀愀挀攀戀漀 漀昀 猀甀椀挀椀搀愀氀 琀栀椀渀欀椀渀最 愀渀搀 戀攀栀愀瘀椀漀爀 ⠀猀甀椀挀椀搀愀氀椀琀礀⤀ 椀渀 挀栀椀氀搀爀攀渀Ⰰ 愀搀漀氀攀猀挀攀渀琀猀Ⰰ 愀渀搀 礀漀甀渀最 愀搀甀氀琀猀 椀渀 猀栀漀爀琀ⴀ琀攀爀洀 猀琀甀搀椀攀猀 漀昀 洀愀樀漀爀 搀攀瀀爀攀猀猀椀瘀攀 搀椀猀漀爀搀攀爀 ⠀䴀䐀䐀⤀ 愀渀搀 漀琀栀攀爀 瀀猀礀挀栀椀愀琀爀椀挀 搀椀猀漀爀搀攀爀猀⸀ 䄀渀礀漀渀攀 挀漀渀猀椀搀攀爀椀渀最 琀栀攀 甀猀攀 漀昀 伀氀攀瀀琀爀漀 漀爀 愀渀礀 漀琀栀攀爀 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀 椀渀 愀 挀栀椀氀搀Ⰰ 愀搀漀氀攀猀挀攀渀琀Ⰰ 漀爀 礀漀甀渀最 愀搀甀氀琀 洀甀猀琀 戀愀氀愀渀挀攀 琀栀椀猀 爀椀猀欀 眀椀琀栀 琀栀攀 挀氀椀渀椀挀愀氀 渀攀攀搀⸀ 匀栀漀爀琀ⴀ琀攀爀洀 猀琀甀搀椀攀猀 搀椀搀 渀漀琀 猀栀漀眀 愀渀 椀渀挀爀攀愀猀攀 椀渀 琀栀攀 爀椀猀欀 漀昀 猀甀椀挀椀搀愀氀椀琀礀 眀椀琀栀 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀猀 挀漀洀瀀愀爀攀搀 琀漀 瀀氀愀挀攀戀漀 椀渀 愀搀甀氀琀猀 戀攀礀漀渀搀 愀最攀 ㈀㐀㬀 琀栀攀爀攀 眀愀猀 愀 爀攀搀甀挀琀椀漀渀 椀渀 爀椀猀欀 眀椀琀栀 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀猀 挀漀洀瀀愀爀攀搀 琀漀 瀀氀愀挀攀戀漀 椀渀 愀搀甀氀琀猀 愀最攀搀 㘀㔀 愀渀搀 漀氀搀攀爀⸀ 䐀攀瀀爀攀猀猀椀漀渀 愀渀搀 挀攀爀琀愀椀渀 漀琀栀攀爀 瀀猀礀挀栀椀愀琀爀椀挀 搀椀猀漀爀搀攀爀猀 愀爀攀 琀栀攀洀猀攀氀瘀攀猀 愀猀猀漀挀椀愀琀攀搀 眀椀琀栀 椀渀挀爀攀愀猀攀猀 椀渀 琀栀攀 爀椀猀欀 漀昀 猀甀椀挀椀搀攀⸀ 倀愀琀椀攀渀琀猀 漀昀 愀氀氀 愀最攀猀 眀栀漀 愀爀攀 猀琀愀爀琀攀搀 漀渀 愀渀琀椀搀攀瀀爀攀猀猀愀渀琀 琀栀攀爀愀瀀礀 猀栀漀甀氀搀 戀攀 洀漀渀椀琀漀爀攀搀 愀瀀瀀爀漀瀀爀椀愀琀攀氀礀 愀渀搀 漀戀猀攀爀瘀攀搀 挀氀漀猀攀氀礀 昀漀爀 挀氀椀渀椀挀愀氀 眀漀爀猀攀渀椀渀最Ⰰ 猀甀椀挀椀搀愀氀椀琀礀Ⰰ 漀爀 甀渀甀猀甀愀氀 挀栀愀渀最攀猀 椀渀 戀攀栀愀瘀椀漀爀⸀ 䘀愀洀椀氀椀攀猀 愀渀搀 挀愀爀攀最椀瘀攀爀猀 猀栀漀甀氀搀 戀攀 愀搀瘀椀猀攀搀 漀昀 琀栀攀 渀攀攀搀 昀漀爀 挀氀漀猀攀 漀戀猀攀爀瘀愀琀椀漀渀 愀渀搀 挀漀洀洀甀渀椀挀愀琀椀漀渀 眀椀琀栀 琀栀攀 瀀爀攀猀挀爀椀戀攀爀⸀ 伀氀攀瀀琀爀漀 椀猀 渀漀琀 愀瀀瀀爀漀瘀攀搀 昀漀爀 甀猀攀 椀渀 瀀攀搀椀愀琀爀椀挀 瀀愀琀椀攀渀琀猀 嬀猀攀攀 圀愀爀渀椀渀最猀 愀渀搀 倀爀攀挀愀甀琀椀漀渀猀 ⠀㔀⸀㄀⤀ 愀渀搀 倀愀琀椀攀渀琀 䌀漀甀渀猀攀氀椀渀最 䤀渀昀漀爀洀愀琀椀漀渀⸀ഀഀ ਍㰀⼀琀搀㸀㰀⼀琀爀㸀㰀⼀琀愀戀氀攀㸀ഀഀ ਍㰀愀 渀愀洀攀㴀∀䤀一䐀䤀䌀䄀吀䤀伀一匀∀㸀ഀഀ ਍㰀倀㸀ഀഀ

    ਍㰀䠀㐀㸀ഀഀ INDICATIONS AND USAGE਍㰀⼀䠀㐀㸀ഀഀ

    ਍伀氀攀瀀琀爀漀∀‡椀猀 椀渀搀椀挀愀琀攀搀 昀漀爀 琀栀攀 琀爀攀愀琀洀攀渀琀 漀昀 洀愀樀漀爀 搀攀瀀爀攀猀猀椀瘀攀 搀椀猀漀爀搀攀爀 ⠀䴀䐀䐀⤀ 椀渀 愀搀甀氀琀猀⸀ 吀栀攀 攀昀昀椀挀愀挀礀 漀昀 伀氀攀瀀琀爀漀 栀愀猀 戀攀攀渀 攀猀琀愀戀氀椀猀栀攀搀 椀渀 愀 琀爀椀愀氀 漀昀 漀甀琀瀀愀琀椀攀渀琀猀 眀椀琀栀 䴀䐀䐀 愀猀 眀攀氀氀 愀猀 椀渀 琀爀椀愀氀猀 眀椀琀栀 琀栀攀 椀洀洀攀搀椀愀琀攀 爀攀氀攀愀猀攀 昀漀爀洀甀氀愀琀椀漀渀 漀昀 琀爀愀稀漀搀漀渀攀⸀ഀഀ

    ਍ഀഀ ਍㰀⼀愀㸀ഀഀ

    ਍㰀⼀倀㸀ഀഀ

    ਍䐀伀匀䄀䜀䔀 䄀一䐀 䄀䐀䴀䤀一䤀匀吀刀䄀吀䤀伀一ഀഀ

    ਍㰀倀㸀ഀഀ Dose Selection਍㰀戀爀㸀ഀഀ
    ਍吀栀攀 爀攀挀漀洀洀攀渀搀攀搀 猀琀愀爀琀椀渀最 搀漀猀攀 漀昀 伀氀攀瀀琀爀漀 椀猀 ㄀㔀  洀最 漀渀挀攀 搀愀椀氀礀 椀渀 愀搀甀氀琀猀⸀ 吀栀攀 搀漀猀攀 洀愀礀 戀攀 椀渀挀爀攀愀猀攀搀 戀礀 㜀㔀 洀最⼀搀愀礀 攀瘀攀爀礀 琀栀爀攀攀 搀愀礀猀 ⠀椀⸀攀⸀Ⰰ 猀琀愀爀琀 ㈀㈀㔀 洀最 漀渀 䐀愀礀 㐀 漀昀 琀栀攀爀愀瀀礀⤀⸀ 吀栀攀 洀愀砀椀洀甀洀 搀愀椀氀礀 搀漀猀攀 猀栀漀甀氀搀 渀漀琀 攀砀挀攀攀搀 ㌀㜀㔀 洀最⸀ഀഀ
      ਍㰀氀椀㸀伀氀攀瀀琀爀漀 琀愀戀氀攀琀猀 猀栀漀甀氀搀 戀攀 琀愀欀攀渀 漀爀愀氀氀礀 愀琀 琀栀攀 猀愀洀攀 琀椀洀攀 攀瘀攀爀礀 搀愀礀Ⰰ 椀渀 琀栀攀 氀愀琀攀 攀瘀攀渀椀渀最 瀀爀攀昀攀爀愀戀氀礀 愀琀 戀攀搀琀椀洀攀Ⰰ 漀渀 愀渀 攀洀瀀琀礀 猀琀漀洀愀挀栀⸀ഀഀ
    • Once an adequate response has been achieved, dosage may be gradually reduced, with subsequent adjustment depending on therapeutic response.਍㰀氀椀㸀倀愀琀椀攀渀琀猀 猀栀漀甀氀搀 戀攀 洀漀渀椀琀漀爀攀搀 昀漀爀 眀椀琀栀搀爀愀眀愀氀 猀礀洀瀀琀漀洀猀 眀栀攀渀 搀椀猀挀漀渀琀椀渀甀椀渀最 琀爀攀愀琀洀攀渀琀 眀椀琀栀 琀爀愀稀漀搀漀渀攀 栀礀搀爀漀挀栀氀漀爀椀搀攀⸀ 吀栀攀 搀漀猀攀 猀栀漀甀氀搀 戀攀 最爀愀搀甀愀氀氀礀 爀攀搀甀挀攀搀 眀栀攀渀攀瘀攀爀 瀀漀猀猀椀戀氀攀⸀ഀഀ
    ਍㰀戀㸀䴀愀椀渀琀攀渀愀渀挀攀 吀爀攀愀琀洀攀渀琀㰀⼀戀㸀ഀഀ
      ਍㰀氀椀㸀吀栀攀 攀昀昀椀挀愀挀礀 漀昀 伀氀攀瀀琀爀漀 昀漀爀 琀栀攀 洀愀椀渀琀攀渀愀渀挀攀 琀爀攀愀琀洀攀渀琀 漀昀 䴀䐀䐀 栀愀猀 渀漀琀 戀攀攀渀 攀瘀愀氀甀愀琀攀搀⸀ 圀栀椀氀攀 琀栀攀爀攀 椀猀 渀漀 戀漀搀礀 漀昀 攀瘀椀搀攀渀挀攀 愀瘀愀椀氀愀戀氀攀 琀漀 愀渀猀眀攀爀 琀栀攀 焀甀攀猀琀椀漀渀 漀昀 栀漀眀 氀漀渀最 愀 瀀愀琀椀攀渀琀 琀爀攀愀琀攀搀 眀椀琀栀 伀氀攀瀀琀爀漀 猀栀漀甀氀搀 挀漀渀琀椀渀甀攀 琀栀攀 搀爀甀最Ⰰ 椀琀 椀猀 最攀渀攀爀愀氀氀礀 爀攀挀漀洀洀攀渀搀攀搀 琀栀愀琀 琀爀攀愀琀洀攀渀琀 戀攀 挀漀渀琀椀渀甀攀搀 昀漀爀 猀攀瘀攀爀愀氀 洀漀渀琀栀猀 愀昀琀攀爀 愀渀 椀渀椀琀椀愀氀 爀攀猀瀀漀渀猀攀⸀ 倀愀琀椀攀渀琀猀 猀栀漀甀氀搀 戀攀 洀愀椀渀琀愀椀渀攀搀 漀渀 琀栀攀 氀漀眀攀猀琀 攀昀昀攀挀琀椀瘀攀 搀漀猀攀 愀渀搀 戀攀 瀀攀爀椀漀搀椀挀愀氀氀礀 爀攀愀猀猀攀猀猀攀搀 琀漀 搀攀琀攀爀洀椀渀攀 琀栀攀 挀漀渀琀椀渀甀攀搀 渀攀攀搀 昀漀爀 洀愀椀渀琀攀渀愀渀挀攀 琀爀攀愀琀洀攀渀琀⸀ഀഀ
    ਍㰀戀㸀䤀洀瀀漀爀琀愀渀琀 䄀搀洀椀渀椀猀琀爀愀琀椀漀渀 䤀渀猀琀爀甀挀琀椀漀渀猀㰀⼀戀㸀ഀഀ
    ਍㰀戀爀㸀ഀഀ Oleptro tablets are scored to provide flexibility in dosing.਍㰀戀爀㸀ഀഀ
    ਍伀氀攀瀀琀爀漀 挀愀渀 戀攀 猀眀愀氀氀漀眀攀搀 眀栀漀氀攀 漀爀 愀搀洀椀渀椀猀琀攀爀攀搀 愀猀 愀 栀愀氀昀 琀愀戀氀攀琀 戀礀 戀爀攀愀欀椀渀最 琀栀攀 琀愀戀氀攀琀 愀氀漀渀最 琀栀攀 猀挀漀爀攀 氀椀渀攀⸀ 䈀爀攀愀欀椀渀最 琀栀攀 琀愀戀氀攀琀 椀渀 栀愀氀昀 搀漀攀猀 渀漀琀 愀昀昀攀挀琀 琀栀攀 挀漀渀琀爀漀氀氀攀搀ⴀ爀攀氀攀愀猀攀 瀀爀漀瀀攀爀琀椀攀猀 漀昀 琀栀攀 琀愀戀氀攀琀⸀ഀഀ
    ਍㰀戀爀㸀ഀഀ In order to maintain its controlled-release properties, Oleptro should not be chewed or crushed.਍㰀戀爀㸀㰀戀爀㸀ഀഀ DOSAGE FORMS AND STRENGTHS਍㰀戀爀㸀ഀഀ
    ਍伀氀攀瀀琀爀漀 琀愀戀氀攀琀猀 愀爀攀 愀瘀愀椀氀愀戀氀攀 椀渀 琀栀攀 昀漀氀氀漀眀椀渀最 猀琀爀攀渀最琀栀猀㨀ഀഀ
    ਍伀氀攀瀀琀爀漀 ㌀   洀最 椀猀 愀 戀攀椀最攀ⴀ漀爀愀渀最攀Ⰰ 挀愀瀀猀甀氀攀ⴀ猀栀愀瀀攀搀 攀砀琀攀渀搀攀搀ⴀ爀攀氀攀愀猀攀 琀愀戀氀攀琀Ⰰ 挀漀愀琀攀搀 愀渀搀 猀挀漀爀攀搀 漀渀 戀漀琀栀 猀椀搀攀猀 眀椀琀栀 䐀䐀匀  㠀㄀ 瀀爀椀渀琀攀搀 漀渀 漀渀攀 猀椀搀攀⸀ 䤀琀 椀猀 猀甀瀀瀀氀椀攀搀 愀猀 昀漀氀氀漀眀猀㨀ഀഀ
    • Bottles of 30 tablets NDC 43595-081-03਍㰀氀椀㸀䈀漀琀琀氀攀猀 漀昀 㤀  琀愀戀氀攀琀猀 一䐀䌀 㐀㌀㔀㤀㔀ⴀ 㠀㄀ⴀ㤀 ഀഀ
    • Bottles of 500 tablets NDC 43595-081-50਍㰀氀椀㸀䈀氀椀猀琀攀爀 瀀愀挀欀猀 漀昀 ㌀  琀愀戀氀攀琀猀 一䐀䌀 㐀㌀㔀㤀㔀ⴀ 㠀㄀ⴀ㌀ 㰀⼀甀氀㸀ഀഀ Store at room temperature (15 – 30ºC) in tight, light-resistant containers.਍㰀⼀倀㸀ഀഀ ਍㰀愀 渀愀洀攀㴀∀匀吀伀刀䄀䜀䔀∀㸀ഀഀ ਍㰀倀㸀ഀഀ

      ਍㰀䠀㐀㸀ഀഀ ਍㰀⼀䠀㐀㸀ഀഀ

      ਍ഀഀ

      ਍ഀഀ
      ਍㰀⼀倀㸀ഀഀ ਍ഀഀ ਍㰀愀 渀愀洀攀㴀∀倀䄀吀䤀䔀一吀开䌀伀唀一匀䔀䰀䤀一䜀∀㸀ഀഀ ਍㰀倀㸀ഀഀ

      ਍㰀䠀㐀㸀ഀഀ PATIENT COUNSELING INFORMATION਍㰀⼀䠀㐀㸀ഀഀ

      ਍㰀戀㸀䤀渀昀漀爀洀愀琀椀漀渀 昀漀爀 倀愀琀椀攀渀琀猀㰀⼀戀㸀ഀഀ

      ਍倀爀攀猀挀爀椀戀攀爀猀 漀爀 漀琀栀攀爀 栀攀愀氀琀栀 瀀爀漀昀攀猀猀椀漀渀愀氀猀 猀栀漀甀氀搀 椀渀昀漀爀洀 瀀愀琀椀攀渀琀猀Ⰰ 琀栀攀椀爀 昀愀洀椀氀椀攀猀Ⰰ 愀渀搀 琀栀攀椀爀 挀愀爀攀最椀瘀攀爀猀 愀戀漀甀琀 琀栀攀 戀攀渀攀昀椀琀猀 愀渀搀 爀椀猀欀猀 愀猀猀漀挀椀愀琀攀搀 眀椀琀栀 琀爀攀愀琀洀攀渀琀 眀椀琀栀 伀氀攀瀀琀爀漀 愀渀搀 猀栀漀甀氀搀 挀漀甀渀猀攀氀 琀栀攀洀 椀渀 椀琀猀 愀瀀瀀爀漀瀀爀椀愀琀攀 甀猀攀⸀ഀഀ

      ਍倀愀琀椀攀渀琀猀 猀栀漀甀氀搀 戀攀 眀愀爀渀攀搀 琀栀愀琀㨀ഀഀ ƒ

      • There is a potential for increased risk of suicidal thoughts especially in children, teenagers and young adults.਍㰀氀椀㸀吀栀攀 昀漀氀氀漀眀椀渀最 猀礀洀瀀琀漀洀猀 猀栀漀甀氀搀 戀攀 爀攀瀀漀爀琀攀搀 琀漀 琀栀攀 瀀栀礀猀椀挀椀愀渀㨀 愀渀砀椀攀琀礀Ⰰ 愀最椀琀愀琀椀漀渀Ⰰ 瀀愀渀椀挀 愀琀琀愀挀欀猀Ⰰ 椀渀猀漀洀渀椀愀Ⰰ 椀爀爀椀琀愀戀椀氀椀琀礀Ⰰ 栀漀猀琀椀氀椀琀礀Ⰰ 愀最最爀攀猀猀椀瘀攀渀攀猀猀Ⰰ 椀洀瀀甀氀猀椀瘀椀琀礀Ⰰ 愀欀愀琀栀椀猀椀愀Ⰰ 栀礀瀀漀洀愀渀椀愀 愀渀搀 洀愀渀椀愀⸀ഀഀ
      • They should inform their physician if they have a history of bipolar disorder, cardiac disease or myocardial infarction.਍㰀氀椀㸀匀攀爀漀琀漀渀椀渀 猀礀渀搀爀漀洀攀 挀漀甀氀搀 漀挀挀甀爀 愀渀搀 猀礀洀瀀琀漀洀猀 洀愀礀 椀渀挀氀甀搀攀 挀栀愀渀最攀猀 椀渀 洀攀渀琀愀氀 猀琀愀琀甀猀 ⠀攀⸀最⸀Ⰰ 愀最椀琀愀琀椀漀渀Ⰰ 栀愀氀氀甀挀椀渀愀琀椀漀渀猀Ⰰ 愀渀搀 挀漀洀愀⤀Ⰰ 愀甀琀漀渀漀洀椀挀 椀渀猀琀愀戀椀氀椀琀礀 ⠀攀⸀最⸀Ⰰ 琀愀挀栀礀挀愀爀搀椀愀Ⰰ 氀愀戀椀氀攀 戀氀漀漀搀 瀀爀攀猀猀甀爀攀Ⰰ 愀渀搀 栀礀瀀攀爀琀栀攀爀洀椀愀⤀Ⰰ 渀攀甀爀漀洀甀猀挀甀氀愀爀 愀戀攀爀爀愀琀椀漀渀猀 ⠀攀⸀最⸀Ⰰ 栀礀瀀攀爀爀攀昀氀攀砀椀愀Ⰰ 椀渀挀漀漀爀搀椀渀愀琀椀漀渀⤀ 愀渀搀⼀漀爀 最愀猀琀爀漀椀渀琀攀猀琀椀渀愀氀 猀礀洀瀀琀漀洀猀 ⠀攀⸀最⸀Ⰰ 渀愀甀猀攀愀Ⰰ 瘀漀洀椀琀椀渀最Ⰰ 愀渀搀 搀椀愀爀爀栀攀愀⤀⸀ഀഀ
      • Trazodone hydrochloride has been associated with the occurrence of priapism.਍㰀氀椀㸀吀栀攀爀攀 椀猀 愀 瀀漀琀攀渀琀椀愀氀 昀漀爀 栀礀瀀漀琀攀渀猀椀漀渀Ⰰ 椀渀挀氀甀搀椀渀最 漀爀琀栀漀猀琀愀琀椀挀 栀礀瀀漀琀攀渀猀椀漀渀 愀渀搀 猀礀渀挀漀瀀攀⸀ഀഀ
      • There is a potential risk of bleeding (including life-threatening hemorrhages) and bleeding related events (including ecchymosis, hematoma, epistaxis, and petechiae) with the concomitant use of trazodone hydrochloride and NSAIDs, aspirin, or other drugs that affect coagulation or bleeding.਍㰀氀椀㸀圀椀琀栀搀爀愀眀愀氀 猀礀洀瀀琀漀洀猀 椀渀挀氀甀搀椀渀最 愀渀砀椀攀琀礀Ⰰ 愀最椀琀愀琀椀漀渀 愀渀搀 猀氀攀攀瀀 搀椀猀琀甀爀戀愀渀挀攀猀Ⰰ 栀愀瘀攀 戀攀攀渀 爀攀瀀漀爀琀攀搀 眀椀琀栀 琀爀愀稀漀搀漀渀攀⸀ 䌀氀椀渀椀挀愀氀 攀砀瀀攀爀椀攀渀挀攀 猀甀最最攀猀琀猀 琀栀愀琀 琀栀攀 搀漀猀攀 猀栀漀甀氀搀 戀攀 最爀愀搀甀愀氀氀礀 爀攀搀甀挀攀搀⸀㰀⼀甀氀㸀ഀഀ

        Patients should be counseled that:਍茀㰀甀氀㸀㰀氀椀㸀伀氀攀瀀琀爀漀 洀愀礀 挀愀甀猀攀 猀漀洀渀漀氀攀渀挀攀 漀爀 猀攀搀愀琀椀漀渀 愀渀搀 洀愀礀 椀洀瀀愀椀爀 琀栀攀 洀攀渀琀愀氀 愀渀搀⼀漀爀 瀀栀礀猀椀挀愀氀 愀戀椀氀椀琀礀 爀攀焀甀椀爀攀搀 昀漀爀 琀栀攀 瀀攀爀昀漀爀洀愀渀挀攀 漀昀 瀀漀琀攀渀琀椀愀氀氀礀 栀愀稀愀爀搀漀甀猀 琀愀猀欀猀⸀ 倀愀琀椀攀渀琀猀 猀栀漀甀氀搀 戀攀 挀愀甀琀椀漀渀攀搀 愀戀漀甀琀 漀瀀攀爀愀琀椀渀最 栀愀稀愀爀搀漀甀猀 洀愀挀栀椀渀攀爀礀Ⰰ 椀渀挀氀甀搀椀渀最 愀甀琀漀洀漀戀椀氀攀猀 甀渀琀椀氀 琀栀攀礀 愀爀攀 爀攀愀猀漀渀愀戀氀礀 挀攀爀琀愀椀渀 琀栀愀琀 琀栀攀 搀爀甀最 琀爀攀愀琀洀攀渀琀 搀漀攀猀 渀漀琀 愀昀昀攀挀琀 琀栀攀洀⸀ഀഀ ƒ
      • Trazodone may enhance the response to alcohol, barbiturates, and other CNS depressants.਍茀 㰀氀椀㸀圀漀洀攀渀 眀栀漀 椀渀琀攀渀搀 琀漀 戀攀挀漀洀攀 瀀爀攀最渀愀渀琀 漀爀 眀栀漀 愀爀攀 戀爀攀愀猀琀昀攀攀搀椀渀最 猀栀漀甀氀搀 搀椀猀挀甀猀猀 眀椀琀栀 愀 瀀栀礀猀椀挀椀愀渀 眀栀攀琀栀攀爀 琀栀攀礀 猀栀漀甀氀搀 挀漀渀琀椀渀甀攀 琀漀 甀猀攀 伀氀攀瀀琀爀漀Ⰰ 猀椀渀挀攀 甀猀攀 椀渀 瀀爀攀最渀愀渀琀 愀渀搀 渀甀爀猀椀渀最 眀漀洀攀渀 椀猀 渀漀琀 爀攀挀漀洀洀攀渀搀攀搀⸀ഀഀ ƒ

        Important Administration Instructions:ƒ਍茀㰀甀氀㸀㰀戀爀㸀㰀氀椀㸀伀氀攀瀀琀爀漀 猀栀漀甀氀搀 戀攀 猀眀愀氀氀漀眀攀搀 眀栀漀氀攀 漀爀 戀爀漀欀攀渀 椀渀 栀愀氀昀 愀氀漀渀最 琀栀攀 猀挀漀爀攀 氀椀渀攀⸀ഀഀ ƒ
      • In order to maintain its controlled-release properties, it should not be chewed or crushed.਍茀㰀氀椀㸀 伀氀攀瀀琀爀漀 猀栀漀甀氀搀 戀攀 琀愀欀攀渀 愀琀 琀栀攀 猀愀洀攀 琀椀洀攀 攀瘀攀爀礀 搀愀礀Ⰰ 椀渀 琀栀攀 氀愀琀攀 攀瘀攀渀椀渀最 瀀爀攀昀攀爀愀戀氀礀 愀琀 戀攀搀琀椀洀攀Ⰰ 漀渀 愀渀 攀洀瀀琀礀 猀琀漀洀愀挀栀⸀茀㰀⼀甀氀㸀ഀഀ

        ਍ഀഀ ਍ഀഀ

        ਍㰀⼀倀㸀ഀഀ

        ਍䰀愀戀漀瀀栀愀爀洀 䔀甀爀漀瀀攀 䰀椀洀椀琀攀搀㰀戀爀㸀 唀渀椀琀 㔀Ⰰ 吀栀攀 匀攀愀瀀漀椀渀琀 䈀甀椀氀搀椀渀最㰀戀爀㸀 㐀㐀⼀㐀㔀 䌀氀漀渀琀愀爀昀 刀漀愀搀Ⰰ 䐀甀戀氀椀渀 ㌀Ⰰ 䤀刀䔀䰀䄀一䐀⸀ഀഀ

        © 2010, Labopharm Europe Limited. All rights reserved.਍㰀戀爀㸀唀⸀匀⸀ 倀愀琀攀渀琀 㘀Ⰰ㘀 㜀Ⰰ㜀㐀㠀ഀഀ

        Oleptro™ is a trademark of Labopharm Inc. Contramid® is a registered trademark of Labopharm Inc.਍㰀戀爀㸀㰀戀爀㸀嬀䘀攀戀爀甀愀爀礀 ㈀ ㄀ 崀ഀഀ

        ਍㰀⼀昀漀渀琀㸀ഀഀ ਍ഀഀ ਍ഀഀ ਍ഀഀ ਍ഀഀ
        ਍ഀഀ ਍ഀഀ

        ਍ഀഀ ਍ഀഀ ਍㰀栀爀㸀ഀഀ

        ਍ഀഀ ਍ഀഀ

        ਍㰀戀爀㸀㰀戀爀㸀ഀഀ ਍ഀഀ ਍ഀഀ ਍㰀戀爀㸀ഀഀ
        ਍㰀愀 栀爀攀昀㴀∀⌀∀ 漀渀䌀氀椀挀欀㴀∀䄀搀搀吀漀䘀愀瘀攀猀开栀瀀⠀⤀∀㸀㰀椀洀最 猀爀挀㴀∀栀琀琀瀀㨀⼀⼀眀眀眀⸀琀栀攀漀搀漀爀愀⸀挀漀洀⼀椀洀愀最攀猀⼀戀漀漀欀洀愀爀欀开戀愀渀渀攀爀⸀最椀昀∀ 愀氀椀最渀㴀∀氀攀昀琀∀ 眀椀搀琀栀㴀∀㄀㜀㘀∀ 栀攀椀最栀琀㴀∀㔀㈀∀ 戀漀爀搀攀爀㴀∀ ∀㸀㰀⼀愀㸀ഀഀ - To bookmark this page (add it to your favorites), please click the image to the left.਍㰀戀爀㸀ഀഀ - If you wish to link to this page, you can do so by referring to the URL address below this line.਍㰀栀爀㸀ഀഀ https://theodora.com/drugs/oleptro_trazodone_hydrochloride_extended-release_tablets_labopharm_europe_ltd.html਍㰀戀爀㸀㰀戀爀㸀ഀഀ This page was last modified 15-FEB-10
        ਍䌀漀瀀礀爀椀最栀琀 ☀挀漀瀀礀 ㄀㤀㤀㔀ⴀ㈀ ㄀  㰀愀 栀爀攀昀㴀∀栀琀琀瀀㨀⼀⼀眀眀眀⸀琀栀攀漀搀漀爀愀⸀挀漀洀⼀椀琀愀⸀栀琀洀氀∀㸀䤀吀䄀㰀⼀愀㸀 愀氀氀 爀椀最栀琀猀 爀攀猀攀爀瘀攀搀⸀ഀഀ
        ਍ഀഀ
  • ਍㰀⼀戀漀搀礀㸀ഀഀ